Cyient Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 13, 2025, 12:43 am

Market Cap	13,972 Cr.
Current Price	1,258
High / Low	2,157/1,050
Stock P/E	22.7
Book Value	478
Dividend Yield	2.38 %
ROCE	16.7 %
ROE	12.9 %
Face Value	5.00
PEG Ratio	2.08

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Cyient Ltd

Competitors of Cyient Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Visesh Infotecnics Ltd	125 Cr.	0.33	0.52/0.33		1.14	0.00 %	0.88 %	0.82 %	1.00
Mudunuru Ltd	26.2 Cr.	8.39	14.4/5.33		0.34	0.00 %	72.9 %	374 %	2.00
Naapbooks Ltd	130 Cr.	121	159/54.0	55.8	20.0	0.00 %	17.4 %	13.6 %	10.0
IB Infotech Enterprises Ltd	21.8 Cr.	170	245/117	27.9	16.8	0.59 %	69.9 %	50.5 %	10.0
Hit Kit Global Solutions Ltd	5.80 Cr.	1.25	1.62/1.13	16.1	2.08	0.00 %	1.92 %	1.94 %	2.00
Industry Average	19,656.73 Cr	604.50		98.34	127.94	0.87%	20.96%	63.00%	6.91

All Competitor Stocks of Cyient Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	1,183	1,181	1,250	1,396	1,618	1,751	1,686	1,778	1,821	1,861	1,676	1,849	1,926
Expenses	972	969	1,057	1,192	1,335	1,429	1,371	1,453	1,495	1,526	1,411	1,552	1,648
Operating Profit	212	212	193	205	283	322	316	326	326	335	265	297	278
OPM %	18%	18%	15%	15%	18%	18%	19%	18%	18%	18%	16%	16%	14%
Other Income	22	49	34	-2	19	-16	-1	7	-32	23	21	51	-17
Interest	10	10	16	31	26	26	28	27	29	32	26	28	20
Depreciation	49	43	51	63	70	73	68	66	66	67	66	66	68
Profit before tax	175	208	160	108	206	208	219	240	200	259	195	254	174
Tax %	25%	26%	27%	27%	24%	21%	23%	24%	23%	24%	24%	27%	26%
Net Profit	132	154	116	79	156	163	169	184	153	197	148	187	128
EPS in Rs	11.95	13.98	10.52	7.16	14.12	14.76	15.20	16.10	13.28	17.06	12.97	16.14	11.02

Last Updated: February 28, 2025, 8:18 pm

Below is a detailed analysis of the quarterly data for Cyient Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 1,926.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,849.00 Cr. (Sep 2024) to 1,926.00 Cr., marking an increase of 77.00 Cr..
For Expenses, as of Dec 2024, the value is 1,648.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,552.00 Cr. (Sep 2024) to 1,648.00 Cr., marking an increase of 96.00 Cr..
For Operating Profit, as of Dec 2024, the value is 278.00 Cr.. The value appears to be declining and may need further review. It has decreased from 297.00 Cr. (Sep 2024) to 278.00 Cr., marking a decrease of 19.00 Cr..
For OPM %, as of Dec 2024, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Sep 2024) to 14.00%, marking a decrease of 2.00%.
For Other Income, as of Dec 2024, the value is -17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Sep 2024) to -17.00 Cr., marking a decrease of 68.00 Cr..
For Interest, as of Dec 2024, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 28.00 Cr. (Sep 2024) to 20.00 Cr., marking a decrease of 8.00 Cr..
For Depreciation, as of Dec 2024, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Sep 2024) to 68.00 Cr., marking an increase of 2.00 Cr..
For Profit before tax, as of Dec 2024, the value is 174.00 Cr.. The value appears to be declining and may need further review. It has decreased from 254.00 Cr. (Sep 2024) to 174.00 Cr., marking a decrease of 80.00 Cr..
For Tax %, as of Dec 2024, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2024) to 26.00%, marking a decrease of 1.00%.
For Net Profit, as of Dec 2024, the value is 128.00 Cr.. The value appears to be declining and may need further review. It has decreased from 187.00 Cr. (Sep 2024) to 128.00 Cr., marking a decrease of 59.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 11.02. The value appears to be declining and may need further review. It has decreased from 16.14 (Sep 2024) to 11.02, marking a decrease of 5.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 3, 2025, 2:51 pm

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	2,206	2,736	3,094	3,586	3,914	4,618	4,427	4,132	4,534	6,016	7,147	7,360
Expenses	1,796	2,335	2,680	3,109	3,394	3,985	3,881	3,557	3,717	5,013	5,844	6,222
Operating Profit	410	401	414	477	520	633	546	575	818	1,003	1,303	1,138
OPM %	19%	15%	13%	13%	13%	14%	12%	14%	18%	17%	18%	15%
Other Income	17	122	112	79	147	131	158	140	112	35	-2	97
Interest	1	6	16	17	20	33	49	43	39	100	116	93
Depreciation	72	71	89	95	105	111	188	194	192	257	267	267
Profit before tax	354	446	421	444	541	620	468	477	698	681	918	875
Tax %	29%	25%	24%	24%	26%	23%	27%	24%	25%	24%	23%	26%
Net Profit	266	351	320	340	403	477	341	364	522	514	703	648
EPS in Rs	23.76	31.43	28.94	30.54	36.00	42.33	31.14	33.06	47.35	46.52	61.57	55.45
Dividend Payout %	21%	25%	24%	34%	36%	35%	48%	51%	51%	56%	49%	47%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	31.95%	-8.83%	6.25%	18.53%	18.36%	-28.51%	6.74%	43.41%	-1.53%	36.77%	-7.82%
Change in YoY Net Profit Growth (%)	0.00%	-40.79%	15.08%	12.28%	-0.17%	-46.87%	35.26%	36.66%	-44.94%	38.30%	-44.59%

Cyient Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	10%
5 Years:	11%
3 Years:	18%
TTM:	3%

Compounded Profit Growth
10 Years:	6%
5 Years:	13%
3 Years:	6%
TTM:	-15%

Stock Price CAGR
10 Years:	9%
5 Years:	44%
3 Years:	17%
1 Year:	-26%

Return on Equity
10 Years:	16%
5 Years:	16%
3 Years:	16%
Last Year:	13%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:29 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	56	56	56	56	56	56	55	55	55	55	55	56	56
Reserves	1,267	1,532	1,788	1,774	2,061	2,288	2,509	2,506	2,902	3,061	3,411	4,203	5,085
Borrowings	0	6	147	214	211	283	368	711	577	573	1,218	788	570
Other Liabilities	283	356	582	668	798	773	927	870	940	1,072	1,815	1,883	1,841
Total Liabilities	1,606	1,950	2,574	2,713	3,126	3,400	3,860	4,142	4,475	4,762	6,500	6,928	7,551
Fixed Assets	335	337	789	657	751	798	978	1,305	1,361	1,345	2,825	2,826	2,904
CWIP	23	7	10	10	26	52	104	146	88	13	44	57	8
Investments	98	93	101	160	196	143	55	41	34	445	518	436	417
Other Assets	1,150	1,514	1,674	1,886	2,153	2,409	2,723	2,650	2,992	2,959	3,113	3,609	4,221
Total Assets	1,606	1,950	2,574	2,713	3,126	3,400	3,860	4,142	4,475	4,762	6,500	6,928	7,551

Below is a detailed analysis of the balance sheet data for Cyient Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹56.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 56.00 Cr..
For Reserves, as of Sep 2024, the value is ₹5,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,203.00 Cr. (Mar 2024) to ₹5,085.00 Cr., marking an increase of 882.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹570.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 788.00 Cr. (Mar 2024) to ₹570.00 Cr., marking a decrease of 218.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹1,841.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,883.00 Cr. (Mar 2024) to ₹1,841.00 Cr., marking a decrease of 42.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹7,551.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,928.00 Cr. (Mar 2024) to ₹7,551.00 Cr., marking an increase of 623.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹2,904.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,826.00 Cr. (Mar 2024) to ₹2,904.00 Cr., marking an increase of 78.00 Cr..
For CWIP, as of Sep 2024, the value is ₹8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2024) to ₹8.00 Cr., marking a decrease of 49.00 Cr..
For Investments, as of Sep 2024, the value is ₹417.00 Cr.. The value appears to be declining and may need further review. It has decreased from 436.00 Cr. (Mar 2024) to ₹417.00 Cr., marking a decrease of 19.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹4,221.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,609.00 Cr. (Mar 2024) to ₹4,221.00 Cr., marking an increase of 612.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹7,551.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,928.00 Cr. (Mar 2024) to ₹7,551.00 Cr., marking an increase of 623.00 Cr..

Notably, the Reserves (5,085.00 Cr.) exceed the Borrowings (570.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	227	362	278	420	296	370	582	856	634	554	726	790
Cash from Investing Activity +	8	-448	-54	-153	-57	-190	-146	-104	-377	-1,006	-537	-145
Cash from Financing Activity +	-43	-32	-111	-93	-136	-232	-446	-253	-544	-109	-266	-58
Net Cash Flow	193	-118	113	174	103	-52	-10	499	-287	-562	-77	587

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	404.00	254.00	200.00	266.00	237.00	265.00	-165.00	-2.00	245.00	0.00	-787.00	1.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	77	79	71	72	66	64	64	60	71	59	68	64
Inventory Days				189	124	156	160	211	110	178	228	177
Days Payable				599	522	453	323	347	314	336	374	260
Cash Conversion Cycle	77	79	71	-337	-331	-233	-99	-76	-133	-99	-78	-19
Working Capital Days	61	65	54	55	39	53	64	64	54	55	49	56
ROCE %	26%	24%	25%	22%	22%	23%	24%	17%	15%	20%	20%	22%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	23.41%	23.41%	23.40%	23.37%	23.36%	23.35%	23.35%	23.20%	23.20%	23.17%	23.16%	23.15%
FIIs	34.72%	34.02%	32.68%	32.62%	31.07%	32.61%	36.57%	35.71%	34.11%	31.04%	29.47%	28.38%
DIIs	22.76%	23.33%	23.88%	23.69%	24.92%	24.88%	21.31%	21.57%	22.69%	25.91%	27.08%	29.72%
Public	19.11%	19.25%	20.04%	19.35%	19.67%	18.18%	17.86%	18.63%	19.13%	19.00%	19.45%	17.93%
Others	0.00%	0.00%	0.00%	0.98%	0.98%	0.98%	0.92%	0.90%	0.89%	0.88%	0.84%	0.82%
No. of Shareholders	1,15,866	1,16,297	1,25,990	1,24,623	1,22,852	1,21,541	1,31,507	1,45,615	1,60,921	1,62,068	1,81,640	1,82,884

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
DSP Small Cap Fund	3,300,697	4.43	524.3	3,300,697	2025-04-22 17:25:37	0%
Kotak Small Cap Fund - Regular Plan	3,018,341	3.94	479.45	3,018,341	2025-04-22 17:25:37	0%
DSP Mid Cap Fund	2,481,398	2.73	394.16	2,481,398	2025-04-22 17:25:37	0%
Nippon India Small Cap Fund	2,477,151	1.05	393.48	2,477,151	2025-04-22 17:25:37	0%
Aditya Birla Sun Life Digital India Fund	1,152,664	4.63	183.09	1,152,664	2025-04-22 01:28:26	0%
ICICI Prudential Smallcap Fund	1,150,829	3.05	182.8	1,150,829	2025-04-22 17:25:37	0%
Franklin India Smaller Companies Fund	1,035,911	1.7	164.55	1,035,911	2025-04-22 02:06:43	0%
360 ONE Focused Equity Fund	889,117	2.89	141.23	889,117	2025-04-22 17:25:37	0%
ICICI Prudential Multicap Fund	571,817	1.04	90.83	571,817	2025-04-22 17:25:37	0%
ICICI Prudential Technology Fund	423,664	0.62	67.3	423,664	2025-04-22 17:25:37	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	62.24	47.03	47.75	33.08	31.14
Diluted EPS (Rs.)	61.71	46.71	47.54	33.06	31.14
Cash EPS (Rs.)	87.34	69.71	64.72	50.75	48.33
Book Value[Excl.RevalReserv]/Share (Rs.)	410.53	313.16	282.01	268.49	232.52
Book Value[Incl.RevalReserv]/Share (Rs.)	410.53	313.16	282.01	268.49	232.52
Revenue From Operations / Share (Rs.)	643.89	543.93	410.72	375.67	402.49
PBDIT / Share (Rs.)	123.31	98.06	84.23	64.99	64.29
PBIT / Share (Rs.)	99.28	74.86	66.82	47.31	47.22
PBT / Share (Rs.)	82.74	61.59	63.26	43.37	42.80
Net Profit / Share (Rs.)	63.31	46.51	47.31	33.07	31.25
NP After MI And SOA / Share (Rs.)	61.51	46.51	47.31	33.07	31.14
PBDIT Margin (%)	19.15	18.02	20.50	17.29	15.97
PBIT Margin (%)	15.41	13.76	16.26	12.59	11.73
PBT Margin (%)	12.84	11.32	15.40	11.54	10.63
Net Profit Margin (%)	9.83	8.55	11.51	8.80	7.76
NP After MI And SOA Margin (%)	9.55	8.55	11.51	8.80	7.73
Return on Networth / Equity (%)	16.03	14.83	16.75	12.30	13.37
Return on Capital Employeed (%)	20.61	18.29	20.92	15.37	16.93
Return On Assets (%)	9.74	7.85	10.91	8.09	8.19
Long Term Debt / Equity (X)	0.06	0.14	0.00	0.01	0.03
Total Debt / Equity (X)	0.10	0.26	0.10	0.09	0.14
Asset Turnover Ratio (%)	1.05	0.54	0.45	0.38	0.46
Current Ratio (X)	2.15	1.58	2.30	2.57	2.24
Quick Ratio (X)	1.86	1.36	2.07	2.43	2.03
Inventory Turnover Ratio (X)	2.19	0.00	0.00	0.00	0.00
Dividend Payout Ratio (NP) (%)	44.81	51.20	56.51	0.00	77.05
Dividend Payout Ratio (CP) (%)	32.22	34.16	41.31	0.00	49.76
Earning Retention Ratio (%)	55.19	48.80	43.49	0.00	22.95
Cash Earning Retention Ratio (%)	67.78	65.84	58.69	0.00	50.24
Interest Coverage Ratio (X)	11.80	10.85	23.66	16.51	14.55
Interest Coverage Ratio (Post Tax) (X)	7.64	6.61	14.29	9.40	8.07
Enterprise Value (Cr.)	21896.86	11188.05	9314.42	5941.90	1944.95
EV / Net Operating Revenue (X)	3.06	1.86	2.05	1.44	0.43
EV / EBITDA (X)	16.00	10.32	10.02	8.31	2.75
MarketCap / Net Operating Revenue (X)	3.10	1.82	2.26	1.73	0.57
Retention Ratios (%)	55.18	48.79	43.48	0.00	22.94
Price / BV (X)	5.20	3.17	3.29	2.41	0.98
Price / Net Operating Revenue (X)	3.10	1.82	2.26	1.73	0.57
EarningsYield	0.03	0.04	0.05	0.05	0.13

After reviewing the key financial ratios for Cyient Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 24, the value is 62.24. This value is within the healthy range. It has increased from 47.03 (Mar 23) to 62.24, marking an increase of 15.21.
For Diluted EPS (Rs.), as of Mar 24, the value is 61.71. This value is within the healthy range. It has increased from 46.71 (Mar 23) to 61.71, marking an increase of 15.00.
For Cash EPS (Rs.), as of Mar 24, the value is 87.34. This value is within the healthy range. It has increased from 69.71 (Mar 23) to 87.34, marking an increase of 17.63.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 410.53. It has increased from 313.16 (Mar 23) to 410.53, marking an increase of 97.37.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 410.53. It has increased from 313.16 (Mar 23) to 410.53, marking an increase of 97.37.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 643.89. It has increased from 543.93 (Mar 23) to 643.89, marking an increase of 99.96.
For PBDIT / Share (Rs.), as of Mar 24, the value is 123.31. This value is within the healthy range. It has increased from 98.06 (Mar 23) to 123.31, marking an increase of 25.25.
For PBIT / Share (Rs.), as of Mar 24, the value is 99.28. This value is within the healthy range. It has increased from 74.86 (Mar 23) to 99.28, marking an increase of 24.42.
For PBT / Share (Rs.), as of Mar 24, the value is 82.74. This value is within the healthy range. It has increased from 61.59 (Mar 23) to 82.74, marking an increase of 21.15.
For Net Profit / Share (Rs.), as of Mar 24, the value is 63.31. This value is within the healthy range. It has increased from 46.51 (Mar 23) to 63.31, marking an increase of 16.80.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 61.51. This value is within the healthy range. It has increased from 46.51 (Mar 23) to 61.51, marking an increase of 15.00.
For PBDIT Margin (%), as of Mar 24, the value is 19.15. This value is within the healthy range. It has increased from 18.02 (Mar 23) to 19.15, marking an increase of 1.13.
For PBIT Margin (%), as of Mar 24, the value is 15.41. This value is within the healthy range. It has increased from 13.76 (Mar 23) to 15.41, marking an increase of 1.65.
For PBT Margin (%), as of Mar 24, the value is 12.84. This value is within the healthy range. It has increased from 11.32 (Mar 23) to 12.84, marking an increase of 1.52.
For Net Profit Margin (%), as of Mar 24, the value is 9.83. This value is within the healthy range. It has increased from 8.55 (Mar 23) to 9.83, marking an increase of 1.28.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.55. This value is within the healthy range. It has increased from 8.55 (Mar 23) to 9.55, marking an increase of 1.00.
For Return on Networth / Equity (%), as of Mar 24, the value is 16.03. This value is within the healthy range. It has increased from 14.83 (Mar 23) to 16.03, marking an increase of 1.20.
For Return on Capital Employeed (%), as of Mar 24, the value is 20.61. This value is within the healthy range. It has increased from 18.29 (Mar 23) to 20.61, marking an increase of 2.32.
For Return On Assets (%), as of Mar 24, the value is 9.74. This value is within the healthy range. It has increased from 7.85 (Mar 23) to 9.74, marking an increase of 1.89.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 23) to 0.06, marking a decrease of 0.08.
For Total Debt / Equity (X), as of Mar 24, the value is 0.10. This value is within the healthy range. It has decreased from 0.26 (Mar 23) to 0.10, marking a decrease of 0.16.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.05. It has increased from 0.54 (Mar 23) to 1.05, marking an increase of 0.51.
For Current Ratio (X), as of Mar 24, the value is 2.15. This value is within the healthy range. It has increased from 1.58 (Mar 23) to 2.15, marking an increase of 0.57.
For Quick Ratio (X), as of Mar 24, the value is 1.86. This value is within the healthy range. It has increased from 1.36 (Mar 23) to 1.86, marking an increase of 0.50.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.19. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 23) to 2.19, marking an increase of 2.19.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 44.81. This value is within the healthy range. It has decreased from 51.20 (Mar 23) to 44.81, marking a decrease of 6.39.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 32.22. This value is within the healthy range. It has decreased from 34.16 (Mar 23) to 32.22, marking a decrease of 1.94.
For Earning Retention Ratio (%), as of Mar 24, the value is 55.19. This value is within the healthy range. It has increased from 48.80 (Mar 23) to 55.19, marking an increase of 6.39.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 67.78. This value is within the healthy range. It has increased from 65.84 (Mar 23) to 67.78, marking an increase of 1.94.
For Interest Coverage Ratio (X), as of Mar 24, the value is 11.80. This value is within the healthy range. It has increased from 10.85 (Mar 23) to 11.80, marking an increase of 0.95.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 7.64. This value is within the healthy range. It has increased from 6.61 (Mar 23) to 7.64, marking an increase of 1.03.
For Enterprise Value (Cr.), as of Mar 24, the value is 21,896.86. It has increased from 11,188.05 (Mar 23) to 21,896.86, marking an increase of 10,708.81.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.06. This value exceeds the healthy maximum of 3. It has increased from 1.86 (Mar 23) to 3.06, marking an increase of 1.20.
For EV / EBITDA (X), as of Mar 24, the value is 16.00. This value exceeds the healthy maximum of 15. It has increased from 10.32 (Mar 23) to 16.00, marking an increase of 5.68.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.10. This value exceeds the healthy maximum of 3. It has increased from 1.82 (Mar 23) to 3.10, marking an increase of 1.28.
For Retention Ratios (%), as of Mar 24, the value is 55.18. This value is within the healthy range. It has increased from 48.79 (Mar 23) to 55.18, marking an increase of 6.39.
For Price / BV (X), as of Mar 24, the value is 5.20. This value exceeds the healthy maximum of 3. It has increased from 3.17 (Mar 23) to 5.20, marking an increase of 2.03.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.10. This value exceeds the healthy maximum of 3. It has increased from 1.82 (Mar 23) to 3.10, marking an increase of 1.28.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Cyient Ltd as of May 12, 2025 is: 1,146.43

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 12, 2025, Cyient Ltd is Overvalued by 8.87% compared to the current share price 1,258.00

Intrinsic Value of Cyient Ltd as of May 12, 2025 is: 1,271.36

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 12, 2025, Cyient Ltd is Undervalued by 1.06% compared to the current share price 1,258.00

Last 5 Year EPS CAGR: 10.90%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 21.67%, which is a positive sign. The stock has a low average Cash Conversion Cycle of -98.17, which is a positive sign. The company has higher reserves (2,645.15 cr) compared to borrowings (435.85 cr), indicating strong financial stability. The company has shown consistent growth in sales (4.08 cr) and profit (578.58 cr) over the years.	The stock has a high average Working Capital Days of 55.75, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cyient Ltd:
1. Net Profit Margin: 9.83%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 20.61% (Industry Average ROCE: 20.96%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 16.03% (Industry Average ROE: 63%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 7.64
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.86
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 22.7 (Industry average Stock P/E: 98.34)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.1
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Cyient Ltd. is a Public Limited Listed company incorporated on 28/08/1991 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L72200TG1991PLC013134 and registration number is 013134. Currently Company is involved in the business activities of Other information technology and computer service activities n.e.c. Company's Total Operating Revenue is Rs. 2413.60 Cr. and Equity Capital is Rs. 55.50 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
IT Consulting & Software	4th Floor, �A� Wing, Hyderabad Telangana 500081	company.secretary@cyient.com http://www.cyient.com

Management
Name	Position Held
Mr. B V R Mohan Reddy	Founder Chairman
Mr. M M Murugappan	Non Executive Chairman
Mr. Krishna Bodanapu	Exec. Vice Chairman & Mang Dir
Mr. Karthikeyan Natarajan	Executive Director & CEO
Ms. Matangi Gowrishankar	Independent Director
Mr. Vikas Sehgal	Independent Director
Mr. Vivek Narayan Gouir	Independent Director
Mr. Nitin Prasad	Independent Director

FAQ

What is the intrinsic value of Cyient Ltd?

Cyient Ltd's intrinsic value (as of 12 May 2025) is ₹1146.43 — 8.87% lower the current market price of 1,258.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 13,972 Cr. market cap, FY2025-2026 high/low of ₹2,157/1,050, reserves of 5,085 Cr, and liabilities of 7,551 Cr.

What is the Market Cap of Cyient Ltd?

The Market Cap of Cyient Ltd is 13,972 Cr..

What is the current Stock Price of Cyient Ltd as on 12 May 2025?

The current stock price of Cyient Ltd as on 12 May 2025 is 1,258.

What is the High / Low of Cyient Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Cyient Ltd stocks is ₹2,157/1,050.

What is the Stock P/E of Cyient Ltd?

The Stock P/E of Cyient Ltd is 22.7.

What is the Book Value of Cyient Ltd?

The Book Value of Cyient Ltd is 478.

What is the Dividend Yield of Cyient Ltd?

The Dividend Yield of Cyient Ltd is 2.38 %.

What is the ROCE of Cyient Ltd?

The ROCE of Cyient Ltd is 16.7 %.

What is the ROE of Cyient Ltd?

The ROE of Cyient Ltd is 12.9 %.

What is the Face Value of Cyient Ltd?

The Face Value of Cyient Ltd is 5.00.